Modernavs.United Therapeutics
MRNA vs UTHR · both in Biotech & innovation, part of the Medicine, pharma & life science value chain: Innovation-driven biotech companies focused on novel treatment modalities.
Moderna is about 1.2× larger than United Therapeutics by market cap; year to date, Moderna leads (+131.5% vs +12.3%).
Side by side
| MRNA | UTHR | |
|---|---|---|
| Market cap | $27.2B | $23.2B |
| Price | $68.27 | $547.06 |
| Today | −10.8% | −1.0% |
| Return YTD | +131.5% | +12.3% |
| Return 1Y | +99.2% | +82.3% |
| P/E | — | 18.0 |
| P/S | 12.2 | 7.3 |
| P/B | 3.7 | 3.9 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
ModernaMRNA
American biotech company based on mRNA technology — known for the covid vaccine, with a pipeline in vaccines and oncology.
Full MRNA profile →United TherapeuticsUTHR
Biopharma in pulmonary hypertension and organ manufacturing (xenotransplantation).
Full UTHR profile →More comparisons in Biotech & innovation
See where MRNA and UTHR sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →